3-[2-(4-propan-2-yloxyanilino)-1-[(1S,5R)-3,3,5-trimethylcyclohexyl]benzimidazol-5-yl]propanoic acid
C28H37N3O3 — CID 118310601
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[2-(4-propan-2-yloxyanilino)-1-[(1S,5R)-3,3,5-trimethylcyclohexyl]benzimidazol-5-yl]propanoic acid
3-[2-(4-propan-2-yloxyanilino)-1-[(1S,5R)-3,3,5-trimethylcyclohexyl]benzimidazol-5-yl]propanoic acid (PubChem CID 118310601) has the molecular formula C28H37N3O3 and a molecular weight of 463.62 g/mol. Its IUPAC name is 3-[2-(4-propan-2-yloxyanilino)-1-[(1S,5R)-3,3,5-trimethylcyclohexyl]benzimidazol-5-yl]propanoic acid.
Molecular Properties
| Compound Name | 3-[2-(4-propan-2-yloxyanilino)-1-[(1S,5R)-3,3,5-trimethylcyclohexyl]benzimidazol-5-yl]propanoic acid |
|---|---|
| PubChem CID | 118310601 |
| Molecular Formula | C28H37N3O3 |
| Molecular Weight | 463.62 g/mol |
| Exact Mass | 463.28 |
| IUPAC Name | 3-[2-(4-propan-2-yloxyanilino)-1-[(1S,5R)-3,3,5-trimethylcyclohexyl]benzimidazol-5-yl]propanoic acid |
| SMILES | CC(C)Oc1ccc(Nc2nc3cc(CCC(=O)O)ccc3n2[C@H]2C[C@H](C)CC(C)(C)C2)cc1 |
| InChI | InChI=1S/C28H37N3O3/c1-18(2)34-23-10-8-21(9-11-23)29-27-30-24-15-20(7-13-26(32)33)6-12-25(24)31(27)22-14-19(3)16-28(4,5)17-22/h6,8-12,15,18-19,22H,7,13-14,16-17H2,1-5H3,(H,29,30)(H,32,33)/t19-,22-/m0/s1 |
| InChIKey | AYBJXJLBRDNWBW-UGKGYDQZSA-N |
| XLogP | 6.97 |
| TPSA | 76.38 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 463.62 |
| LogP ≤ 5 | 6.97 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118310601 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.